FULC
Fulcrum Therapeutics Inc.
Latest News for FULC
In a report released today, from Roth MKM reiterated a Buy rating on Fulcrum Therapeutics, with a price target of $15.00. In addition to Roth MKM, ......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Incyte (INCY – Research Report), Fulcrum Therapeut......
In a report released on December 6, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Fulcrum Therapeutics, with a price target of $......
In a report released today, James Condulis from Stifel Nicolaus maintained a Buy rating on Fulcrum Therapeutics, with a price target of $20.00. Con......
Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Fulcrum Therapeutics today and set a price target of $15.00. Biegler covers the Heal......
Fulcrum Therapeutics ( ($FULC) ) just unveiled an announcement. On December 6, 2025, Fulcrum Therapeutics announced positive initial results from t......
Truist Financial analyst maintained a Buy rating on Fulcrum Therapeutics yesterday. The company’s shares closed yesterday at $9.06. In addition to ......
News data is sourced from MarketXLS API and updated regularly.
Showing 7 of 7 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FULC | $13.00 | +1.6% | 1.63M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Fulcrum Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW